Wave Life Sciences (WVE) Enterprise Value (2015 - 2026)

Wave Life Sciences (WVE) has 13 years of Enterprise Value data on file, last reported at -$368.0 million in Q2 2026.

• Quarterly Enterprise Value fell 76.5% year-over-year to -$368.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$368.0 million (down 76.5% YoY) and the FY2025 annual result came in at -$602.1 million, down 99.31% from the prior year.
• Enterprise Value climbed to -$368.0 million in Q2 2026, from -$544.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$88.5 million in Q4 2022 to a low of -$602.1 million in Q4 2025.
• A 5-year average of -$244.5 million and a median of -$198.3 million in 2023 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 41.22% — and 2023, when it sank 126.39%.
• Tracing WVE's Enterprise Value over 5 years: stood at -$88.5 million in 2022, then tumbled by 126.39% to -$200.4 million in 2023, then sank by 50.77% to -$302.1 million in 2024, then sank by 99.31% to -$602.1 million in 2025, then surged by 38.88% to -$368.0 million in 2026.
• The last three Enterprise Value figures came in at -$368.0 million (Q2 2026), -$544.6 million (Q1 2026), and -$602.1 million (Q4 2025), per Business Quant data.